Matheson advised Auxilium Pharmaceuticals Inc. on its $2.6 billion merger with Endo International plc. The transaction, which was announced on 9 October 2014, has been unanimously approved by the boards of directors of both companies. The transaction is valued at USD 2.6 billion, including the repayment and assumption of debt. The deal is expected to close in H1 2015 and is subject to shareholder and regulatory approval.
The Matheson team included corporate partners Tim Scanlon and George Brady, tax partner Shane Hogan and Head of US Offices, John Ryan.
Source: www.matheson.com
